Correlation Between Assertio Therapeutics and Amneal Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Amneal Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Amneal Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Assertio Therapeutics and Amneal Pharmaceuticals, Class, you can compare the effects of market volatilities on Assertio Therapeutics and Amneal Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Amneal Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Amneal Pharmaceuticals,.

Diversification Opportunities for Assertio Therapeutics and Amneal Pharmaceuticals,

-0.1

Correlation Coefficient

Assertio Therapeutics  Amneal Pharmaceuticals,

Good diversification

The 3 months correlation between Assertio and Amneal is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Amneal Pharmaceuticals, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amneal Pharmaceuticals, and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Amneal Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amneal Pharmaceuticals, has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Amneal Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Assertio Therapeutics and Amneal Pharmaceuticals,

Given the investment horizon of 90 days Assertio Therapeutics is expected to under-perform the Amneal Pharmaceuticals,. In addition to that, Assertio Therapeutics is 2.85 times more volatile than Amneal Pharmaceuticals, Class. It trades about -0.01 of its total potential returns per unit of risk. Amneal Pharmaceuticals, Class is currently generating about -0.03 per unit of volatility. If you would invest  841.00  in Amneal Pharmaceuticals, Class on September 3, 2024 and sell it today you would lose (14.00) from holding Amneal Pharmaceuticals, Class or give up 1.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Assertio Therapeutics  vs.  Amneal Pharmaceuticals, Class

Assertio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Assertio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Assertio Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Amneal Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amneal Pharmaceuticals, Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Amneal Pharmaceuticals, is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Assertio Therapeutics and Amneal Pharmaceuticals,

The main advantage of trading using opposite Assertio Therapeutics and Amneal Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Amneal Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amneal Pharmaceuticals, will offset losses from the drop in Amneal Pharmaceuticals,'s long position.

The idea behind Assertio Therapeutics and Amneal Pharmaceuticals, Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.